Topics
Adancing the Science in Ocular Oncology
Exploring the Rationale for Steroid Use in Noninfectious Posterior Uveitis
Sponsored by Santen Pharmaceutical Co. Ltd.
View Supplement
Highlights from the "Faster and Smaller" Symposium
Sponsored by Alcon
Anti-VEGF Therapies: Ocular and Systemic Impact
Supported by an educational grant from Regeneron Pharmaceuticals.
The Ultimate Technician’s Survival Guide
Sponsored by advertising from Regeneron and Carl Zeiss Meditec, Inc.
Meeting Notes from the 42nd Annual Meeting of the ARDS
Innovations in Retina
Beyond the Clinical Trials: The Comanagement of Patients With Diabetes: Coordinating Care to Achieve Better Outcomes
Supported by advertising from Allergan Inc., and Heidelberg Engineering
View Insert
Clinical Case Compendium
Supported with advertising by Alcon
What You Need to Know About ... Diabetic Macular Edema
Prepared and Sponsored by Regeneron
State of the Art
Beyond the Clinical Trials: Understanding Disease Trends in Diabetes and Their Correlation to Eye Manifestations
The Evolving Management of Vitreomacular Interface Disorders: When To Treat
Supported by an unrestricted educational grant from ThromboGenics
Changing Patterns in Treatments of Diabetic Macular Edema for Patients Who Are Pseudophakic or Phakic and Scheduled for Cataract Surgery
Sponsored by Allergan, Inc.
Anti-VEGF Therapy for Diabetic Macular Edema (Part 1 of 2)
Sponsored by Novartis Pharma AG
Ocular Drug Delivery
Safety and Efficacy of VEGF-Neutralizing Drugs for Intraocular Use
Supported via advertising from Genentech
Ocriplasmin Clinical Update
Sponsored by ThromboGenics and Alcon
New Modalities for Treating Diseases of the Choroid and Retina
Sponsored by Clearside Biomedical, Inc.
Advancing the Art and Science of AMD Management
Treatments, Triggers, and Decisions in Retinal Disease Diagnosis and Management
Supported via advertising from Allergan, Inc.; and Optos PLC
Individualized Dosing in Wet Age-Related Macular Degeneration
Macular Edema Secondary to Retinal Vasculature Disease
Current Insights Into the Management of Diabetic Macular Edema
Supported by an unrestricted educational grant from Regeneron
A Global Focus on Pediatric Retina
Rethink Vitreomacular Traction
Anti-VEGF Therapy for Diabetic Macular Edema
Controversies in Retina Surgery
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
